Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 58

1.

In vitro-targeted gene identification in patients with hepatitis C using a genome-wide microarray technology.

Hagist S, Sültmann H, Millonig G, Hebling U, Kieslich D, Kuner R, Balaguer S, Seitz HK, Poustka A, Mueller S.

Hepatology. 2009 Feb;49(2):378-86. doi: 10.1002/hep.22677.

PMID:
19177570
2.

Insights into the pathobiology of hepatitis C virus-associated cirrhosis: analysis of intrahepatic differential gene expression.

Shackel NA, McGuinness PH, Abbott CA, Gorrell MD, McCaughan GW.

Am J Pathol. 2002 Feb;160(2):641-54.

3.

Differential microRNA expression between hepatitis B and hepatitis C leading disease progression to hepatocellular carcinoma.

Ura S, Honda M, Yamashita T, Ueda T, Takatori H, Nishino R, Sunakozaka H, Sakai Y, Horimoto K, Kaneko S.

Hepatology. 2009 Apr;49(4):1098-112. doi: 10.1002/hep.22749.

PMID:
19173277
4.

Accelerated hepatic fibrosis in patients with combined hereditary hemochromatosis and chronic hepatitis C infection.

Diwakaran HH, Befeler AS, Britton RS, Brunt EM, Bacon BR.

J Hepatol. 2002 May;36(5):687-91.

PMID:
11983453
5.

Gene expression profiling of fixed tissues identified hypoxia-inducible factor-1α, VEGF, and matrix metalloproteinase-2 as biomarkers of lymph node metastasis in hepatocellular carcinoma.

Xiang ZL, Zeng ZC, Fan J, Tang ZY, Zeng HY, Gao DM.

Clin Cancer Res. 2011 Aug 15;17(16):5463-72. doi: 10.1158/1078-0432.CCR-10-3096. Epub 2011 Jun 28.

6.
7.

Hemochromatosis gene mutations in chronic hepatitis C patients with and without liver siderosis.

Negro F, Samii K, Rubbia-Brandt L, Quadri R, Male PJ, Zarski JP, Baud M, Giostra E, Beris P, Hadengue A.

J Med Virol. 2000 Jan;60(1):21-7.

PMID:
10568758
8.

In situ enzymatic oligonucleotide amplification of hepatitis C virus-RNA in liver biopsy specimens (reverse transcriptase in situ polymerase chain reaction) after orthotopic liver transplantation for hepatitis C-related liver disease.

Fragulidis GP, Cirocco RE, Weppler D, Berho M, Gillian G, Markou M, Viciana A, Esquenazi V, Nery JR, Miller J, Reddy KR, Tzakis AG.

Transplantation. 1998 Dec 15;66(11):1472-6.

PMID:
9869088
9.

Identification of differentially expressed genes in human bladder cancer through genome-wide gene expression profiling.

Kawakami K, Enokida H, Tachiwada T, Gotanda T, Tsuneyoshi K, Kubo H, Nishiyama K, Takiguchi M, Nakagawa M, Seki N.

Oncol Rep. 2006 Sep;16(3):521-31.

PMID:
16865252
10.

Transforming growth factor beta in hepatitis C virus infection: in vivo and in vitro findings.

Ray S, Broor SL, Vaishnav Y, Sarkar C, Girish R, Dar L, Seth P, Broor S.

J Gastroenterol Hepatol. 2003 Apr;18(4):393-403.

PMID:
12653887
11.

Hereditary hemochromatosis in liver transplantation.

Fiel MI, Schiano TD, Bodenheimer HC, Thung SN, King TW, Varma CR, Miller CM, Brunt EM, Starnes S, Prass C, Wolff RK, Bacon BR.

Liver Transpl Surg. 1999 Jan;5(1):50-6.

12.

cDNA microarray analysis to compare HCV subgenomic replicon cells with their cured cells.

Abe K, Ikeda M, Dansako H, Naka K, Shimotohno K, Kato N.

Virus Res. 2005 Jan;107(1):73-81.

PMID:
15567036
13.

Differential cellular gene expression induced by hepatitis B and C viruses.

Otsuka M, Aizaki H, Kato N, Suzuki T, Miyamura T, Omata M, Seki N.

Biochem Biophys Res Commun. 2003 Jan 10;300(2):443-7.

PMID:
12504104
14.

[Limits of immunoserologic and molecular diagnosis of hepatitis C].

Trepo C, Alonso C, Li JS, Qu D, Laurent F, Vitvitski L.

Nucl Med Biol. 1994 Apr;21(3):419-31. French.

PMID:
9296765
15.

Combined functional genome survey of therapeutic targets for hepatocellular carcinoma.

Satow R, Shitashige M, Kanai Y, Takeshita F, Ojima H, Jigami T, Honda K, Kosuge T, Ochiya T, Hirohashi S, Yamada T.

Clin Cancer Res. 2010 May 1;16(9):2518-28. doi: 10.1158/1078-0432.CCR-09-2214. Epub 2010 Apr 13.

16.

Increased cancer risk in a cohort of 230 patients with hereditary hemochromatosis in comparison to matched control patients with non-iron-related chronic liver disease.

Fracanzani AL, Conte D, Fraquelli M, Taioli E, Mattioli M, Losco A, Fargion S.

Hepatology. 2001 Mar;33(3):647-51.

PMID:
11230745
17.

Activation of fetal promoters of insulinlike growth factors II gene in hepatitis C virus-related chronic hepatitis, cirrhosis, and hepatocellular carcinoma.

Nardone G, Romano M, Calabrò A, Pedone PV, de Sio I, Persico M, Budillon G, Bruni CB, Riccio A, Zarrilli R.

Hepatology. 1996 Jun;23(6):1304-12.

PMID:
8675143
18.

Hepatic and extrahepatic expression of the new iron regulatory protein hemojuvelin.

Rodriguez Martinez A, Niemelä O, Parkkila S.

Haematologica. 2004 Dec;89(12):1441-5.

19.

Hepatitis C virus-induced oxidative stress suppresses hepcidin expression through increased histone deacetylase activity.

Miura K, Taura K, Kodama Y, Schnabl B, Brenner DA.

Hepatology. 2008 Nov;48(5):1420-9. doi: 10.1002/hep.22486.

PMID:
18671304
20.

Hepatitis C virus infection in sporadic fulminant viral hepatitis in North India: cause or co-factor?

Jain A, Kar P, Madan K, Das UP, Budhiraja S, Gopalkrishna V, Sharma JK, Das BC.

Eur J Gastroenterol Hepatol. 1999 Nov;11(11):1231-7.

PMID:
10563532

Supplemental Content

Support Center